You are here

  • Home
  • Archive
  • Volume 4, Issue 12
  • Deliberative democracy and cancer screening consent: a randomised control trial of the effect of a community jury on men's knowledge about and intentions to participate in PSA screening

Article Text

Article menu

Download PDFPDF

XML
Public health
Research
Deliberative democracy and cancer screening consent: a randomised control trial of the effect of a community jury on men's knowledge about and intentions to participate in PSA screening
  1. Rae Thomas1,
  2. Paul Glasziou1,
  3. Lucie Rychetnik2,3,
  4. Geraldine Mackenzie4,
  5. Robert Gardiner5,
  6. Jenny Doust1
  1. 1Faculty of Health Sciences and Medicine, Centre for Research in Evidence-Based Practice (CREBP), Bond University, Gold Coast, Queensland, Australia
  2. 2School of Medicine, University of Notre Dame, Sydney, New South Wales, Australia
  3. 3School of Public Health, University of Sydney, Sydney, New South Wales, Australia
  4. 4Faculty of Law, Bond University, Gold Coast, Queensland, Australia
  5. 5Department of Urology, University of Queensland Centre for Clinical Research, Royal Brisbane & Women's Hospital, Gold Coast, Queensland, Australia
  1. Correspondence to Dr Rae Thomas; rthomas{at}bond.edu.au

Abstract

Objective Prostate-specific antigen (PSA) screening is controversial. A community jury allows presentation of complex information and may clarify how participants view screening after being well-informed. We examined whether participating in a community jury had an effect on men's knowledge about and their intention to participate in PSA screening.

Design Random allocation to either a 2-day community jury or a control group, with preassessment, postassessment and 3-month follow-up assessment.

Setting Participants from the Gold Coast (Australia) recruited via radio, newspaper and community meetings.

Participants Twenty-six men aged 50–70 years with no previous diagnosis of prostate cancer.

Intervention The control group (n=14) received factsheets on PSA screening. Community jury participants (n=12) received the same factsheets and further information about screening for prostate cancer. In addition, three experts presented information on PSA screening: a neutral scientific advisor provided background information, one expert emphasised the potential benefits of screening and another expert emphasised the potential harms. Participants discussed information, asked questions to the experts and deliberated on personal and policy decisions.

Main outcome and measures Our primary outcome was change in individual intention to have a PSA screening test. We also assessed knowledge about screening for prostate cancer.

Results Analyses were conducted using intention-to-treat. Immediately after the jury, the community jury group had less intention-to-screen for prostate cancer than men in the control group (effect size=−0.6 SD, p=0.05). This was sustained at 3-month follow-up. Community jury men also correctly identified PSA test accuracy and considered themselves more informed (effect size=1.2 SD, p<0.001).

Conclusions Evidence-informed deliberation of the harms and benefits of PSA screening effects men's individual choice to be screened for prostate cancer. Community juries may be a valid method for eliciting target group input to policy decisions.

Trial registration number Australian and New Zealand Clinical Trials Registry (ACTRN12612001079831).

  • PRIMARY CARE
  • PUBLIC HEALTH
  • Prostate Specific Antigen testing
  • Prostate Cancer

This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/

https://doi.org/10.1136/bmjopen-2014-005691

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    View Full Text